Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Clin Breast Cancer. 2013 Oct 25;14(2):e21–e31. doi: 10.1016/j.clbc.2013.10.003

Table 4.

Effects of Race and Age upon Quality of Life (QOL)

Domain N SD Min Median Max 95% CI p-value*

White
Negative Feelings 846 11.2 4.2 4 10 28 10.9 – 11.5 0.4065
rev Positive Feelings 799 10.7 5.0 4 10 28 10.4 – 11.1 0.5147
Cognitive Problems 826 12.0 5.0 4 11 28 11.6 – 12.3 0.1566
Physical Pain 822 9.3 5.2 4 8 28 9.0 – 9.7 0.0626
Sexual Interest 803 7.4 3.8 2 7 14 7.2 – 7.7 0.1343
Sexual Function 819 6.3 3.6 2 6 14 6.1 – 6.5 0.0988
rev Fatigue a 830 12.1 5.3 4 11 27 11.7 – 12.5 0.0523
Social Avoidance 798 8.8 4.9 4 8 28 8.5 – 9.2 0.0058
Financial Problems 825 9.5 6.5 4 7 28 9.1 – 9.9 0.0010
rev Benefits of Cancer 830 12.9 6.0 4 12 28 12.4 – 13.3 0.0105
Distress about Family b 834 12.9 6.9 4 10.7 28 12.5 – 13.4 0.0028
Appearance Concerns 822 11.6 6.0 4 10 28 11.2 – 12.0 0.5331
Distress about Recurrence 816 13.7 6.2 4 12 28 13.3 – 14.1 0.5284
Summary Score: Generic c 721 77.0 26.7 28 73 166 75.1 – 79.0 0.3701
Summary Score: Cancer Specific d 785 44.1 17.9 15 41 102 42.8 – 45.3 0.0086
Spanish / Hispanic
Negative Feelings 106 11.6 5.2 4 11 26 10.6 – 12.6 ---
rev Positive Feelings 102 10.0 5.7 4 8 26 8.8 – 11.1 ---
Cognitive Problems 106 12.3 5.7 4 11 28 11.2 – 13.4 ---
Physical Pain 105 9.7 5. 4 9 25 8.7 – 10.7 ---
Sexual Interest 98 6.7 4.1 2 6 14 5.9 – 7.5 ---
Sexual Function 103 6.0 3.8 2 5 14 5.3 – 6.7 ---
rev Fatigue a 106 12.6 5.6 4 12 28 11.5 – 13.7 ---
Social Avoidance 97 9.6 5.6 4 8 26 8.4 – 10.7 ---
Financial Problems 103 11.2 7.1 4 9 28 9.8 – 12.5 ---
rev Benefits of Cancer 107 11.1 6.5 4 9 28 9.9 – 12.4 ---
Distress about Family b 109 15.2 7.7 4 13.3 28 13.8 – 16.7 ---
Appearance Concerns 104 12.2 6.3 4 11.5 28 11.0 – 13.4 ---
Distress about Recurrence 104 14.5 6.7 4 14 28 13.2 – 15.8 ---
Summary Score: Generic c 83 80.0 32.7 29 74 168 72.8 – 87.1 ---
Summary Score: Cancer Specific d 96 49.1 18.9 15 45.5 102 45.3 – 53.0 ---
Black
Negative Feelings 88 12.0 5.5 4 10.5 26 10.8 – 13.1 ---
rev Positive Feelings 84 10.5 5.4 4 9 25 9.3 – 11.7 ---
Cognitive Problems 88 12.5 6.2 4 11 27 11.2 – 13.8 ---
Physical Pain 87 10.9 6.7 4 9 27 9.5 – 12.3 ---
Sexual Interest 88 6.9 4.0 2 6 14 6.0 – 7.7 ---
Sexual Function 90 5.4 3.7 2 4 14 4.6 – 6.1 ---
rev Fatigue a 91 13.2 5.9 4 12 26 11.9 – 14.4 ---
Social Avoidance 87 10.8 6.7 4 9 28 9.4 – 12.2 ---
Financial Problems 90 12.1 7.6 4 10 28 10.5 – 13.7 ---
rev Benefits of Cancer 90 11.4 5.9 4 11 28 10.2 – 12.7 ---
Distress about Family b 91 14.7 7.6 4 12 28 13.1 – 16.2 ---
Appearance Concerns 89 12.1 6.6 4 11 28 10.7 – 13.5 ---
Distress about Recurrence 90 14.1 6.4 4 13 28 12.7 – 15.4 ---
Summary Score: Generic c 70 81.3 36.2 33 67.5 173 72.6 – 89.9 ---
Summary Score: Cancer Specific d 85 49.1 20.4 15 47 105 44.7 – 53.5 ---
Asian / Pacific Islander
Negative Feelings 36 11.6 4.4 4 11 25 10.1 – 13.1 ---
rev Positive Feelings 35 10.3 4.6 4 10 20 8.8 – 11.9 ---
Cognitive Problems 37 10.3 4.4 4 9 21 8.8 – 11.7 ---
Physical Pain 37 9.3 5.0 4 8 28 7.6 – 11.0 ---
Sexual Interest 34 6.6 3.6 2 6 14 5.4 – 7.9 ---
Sexual Function 35 5.8 3.2 2 5 14 4.7 – 6.9 ---
rev Fatigue a 37 10.4 4.9 4 10 23 8.8 – 12.0 ---
Social Avoidance 35 9.5 3.9 4 9 17 8.2 – 10.8 ---
Financial Problems 35 9.7 6.1 4 9 23 7.7 – 11.8 ---
rev Benefits of Cancer 37 12.3 6.3 4 13 25 10.2 – 14.4 ---
Distress about Family b 37 12.6 6.4 4 12 28 10.5 – 14.8 ---
Appearance Concerns 37 10.8 5.6 4 10 24 8.9 – 12.7 ---
Distress about Recurrence 37 13.1 6.6 4 12 28 10.9 – 15.3 ---
Summary Score: Generic c 31 72.4 27.2 34 68 153 62.4 – 82.3 ---
Summary Score: Cancer Specific d 35 42.8 20.4 15 40 92 35.8 – 49.8 ---
Age < 40 Years
Negative Feelings 441 11.7 4.5 4 11 26 11.2 – 12.1 0.0532
rev Positive Feelings 426 10.6 5.1 4 10 28 10.2 – 11.1 0.9024
Cognitive Problems 443 12.1 5.3 4 12 26 11.6 – 12.5 0.6642
Physical Pain 443 9.0 5.2 4 8 28 8.6 – 9.5 0.0300
Sexual Interest 430 6.8 3.9 2 6 14 6.5 – 7.2 0.0016
Sexual Function 442 5.9 3.5 2 5 14 5.6 – 6.2 0.0523
rev Fatigue a 445 12.1 5.2 4 11 27 11.6 – 12.6 0.6441
Social Avoidance 431 9.1 5.2 4 8 28 8.6 – 9.6 0.9173
Financial Problems 441 10.2 6.9 4 8 28 9.6 – 10.9 0.1400
rev Benefits of Cancer 444 12.1 6.0 4 11 28 11.6 – 12.7 0.0484
Distress about Family b 447 13.5 7.1 4 12 28 12.9 – 14.2 0.3587
Appearance Concerns 442 12.0 6.1 4 11 28 11.4 – 12.6 0.1234
Distress about Recurrence 435 14.3 6.5 4 13 28 13.6 – 14.9 0.0498
Summary Score: Generic c 390 77.3 28.3 28 71.5 166 74.5 – 80.1 0.9011
Summary Score: Cancer Specific d 417 46.2 18.7 15 44 102 44.4 – 48.0 0.0611
Age ≥ 40 Years
Negative Feelings 614 11.1 4.4 4 10 28 10.8 – 11.5 ---
rev Positive Feelings 598 10.6 5.1 4 9 25 10.2 – 11.0 ---
Cognitive Problems 618 11.9 5.2 4 11 28 11.5 – 12.3 ---
Physical Pain 612 9.8 5.4 4 8 28 9.3 – 10.2 ---
Sexual Interest 597 7.6 3.8 2 7 14 7.3 – 7.9 ---
Sexual Function 609 6.4 3.7 2 6 14 6.1 – 6.6 ---
rev Fatigue a 623 12.2 5.6 4 11 28 11.8 – 12.7 ---
Social Avoidance 590 9.1 5.1 4 8 28 8.7 – 9.5 ---
Financial Problems 616 9.6 6.6 4 7 28 9.1 – 10.1 ---
rev Benefits of Cancer 624 12.9 6.1 4 12 28 12.4 – 13.3 ---
Distress about Family b 628 13.1 7.0 4 10.7 28 12.6 – 13.7 ---
Appearance Concerns 614 11.4 6.0 4 10 28 10.9 – 11.9 ---
Distress about Recurrence 616 13.5 6.0 4 12 28 13.0 – 14.0 ---
Summary Score: Generic c 519 77.5 28.0 28 73 173 75.1 – 80.0 ---
Summary Score: Cancer Specific d 588 44.0 18.1 15 40 105 42.5 – 45.5 ---
a

(reverse Q1) + Q5 + Q11 + Q14

b

Q31 + Q34 + Q42 +Mean(Q31, Q34, Q42)

c

Sum (Negative Feelings Subscale, Positive Feelings Subscale (reversed), Cognitive Problems Subscale, Physical Pain Subscale, Sexual Problems Subscale, Energy/Fatigue Subscale (reverse Q1), Social Avoidance Subscale)

d

Sum (Financial Subscale, Distress Family Subscale (Q31 + Q34 + Q42), Appearance Subscale, Distress Recurrence Subscale)

*

p-value for comparing scores for patients age < 40 years at diagnosis versus patients age ≥ 40 years at diagnosis. Using a Bonferroni correction due to performance of 15 tests suggests using a significance level of 0.05/15 = 0.0033 for each test.